<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11279">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02960100</url>
  </required_header>
  <id_info>
    <org_study_id>OSU-16109</org_study_id>
    <secondary_id>NCI-2016-01449</secondary_id>
    <secondary_id>P30CA016058</secondary_id>
    <nct_id>NCT02960100</nct_id>
  </id_info>
  <brief_title>mHealth Intervention in Increasing HPV Vaccinations in College Students</brief_title>
  <official_title>S.M.A.R.T. (Students Motivating and Acting in Real-Time) eStudy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized pilot trial studies how well a mobile health (mHealth) intervention works in
      increasing human papillomavirus (HPV) vaccination among college students at the Ohio State
      University. mHealth educational intervention may communicate information about HPV
      vaccination and increase HPV vaccine uptake in college students.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. Pilot test an mHealth HPV vaccine intervention for college students to establish
      feasibility and acceptability.

      II. Obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention
      increases HPV vaccine initiation compared to the control group.

      SECONDARY OBJECTIVES:

      I. Examine whether the mHealth HPV vaccine intervention affects secondary outcomes compared
      to the control group.

      OUTLINE: Participants are randomized to 1 of 2 arms.

      ARM I: Participants receive targeted HPV vaccine narrative-style video via the
      mobile-friendly website. Participants also receive monthly HPV vaccination reminders via
      email or by text message.

      ARM II: Participants receive standard information about HPV and then HPV vaccine information
      statement (VIS) via the mobile-friendly website.

      After completion of study, participants are followed up at 3 and 7 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Receipt of the first dose of HPV vaccine in intervention and control group</measure>
    <time_frame>Up to 7 months</time_frame>
    <description>Will obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant satisfaction scores</measure>
    <time_frame>Up to 7 months</time_frame>
    <description>Acceptability and feasibility will be established by examining participant satisfaction with study materials.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Receipt of the second and third doses of the HPV vaccine series by intervention and control group</measure>
    <time_frame>Up to 7 months</time_frame>
    <description>Will examine whether the mHealth HPV vaccine intervention affects the receipt of the second and third doses of the HPV vaccine series compared to the control group.</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in potential mediators between intervention or control group and HPV vaccination</measure>
    <time_frame>Up to 7 months</time_frame>
    <description>Will examine whether the mHealth HPV vaccine intervention affects changes in potential mediators between intervention group and HPV vaccination compared to the control group.</description>
  </other_outcome>
  <other_outcome>
    <measure>Student feedback based on satisfaction and usability data assessed by surveys</measure>
    <time_frame>Up to 7 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of times participant logged in to view the narrative or HPV VIS</measure>
    <time_frame>Up to 7 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of times participants in the intervention group used the link to make an appointment at the health center</measure>
    <time_frame>Up to 7 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Total time spent viewing the narrative-style video or HPV VIS</measure>
    <time_frame>Up to 7 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Healthy Subject</condition>
  <arm_group>
    <arm_group_label>Arm I (mHealth HPV vaccine intervention)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II (standard HPV information and HPV VIS)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive standard information with the HPV Vaccine Information Statement via the mobile-friendly website.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Informational Intervention</intervention_name>
    <description>Receive standard HPV vaccine information (HPV VIS)</description>
    <arm_group_label>Arm II (standard HPV information and HPV VIS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Media Intervention</intervention_name>
    <description>Receive targeted HPV vaccine narrative-style video</description>
    <arm_group_label>Arm I (mHealth HPV vaccine intervention)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (mHealth HPV vaccine intervention)</arm_group_label>
    <arm_group_label>Arm II (standard HPV information and HPV VIS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Currently enrolled as a first year Ohio State University (OSU) student on the
             Columbus campus

          -  Being able to read English

          -  Not having received any doses of the HPV vaccine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mira Katz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University Comprehensive Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>The Ohio State University Comprehensive Cancer Center</last_name>
    <phone>1-800-293-5066</phone>
    <email>Jamesline@osumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paul L Reiter, PhD</last_name>
    <phone>614-366-4265</phone>
    <email>paul.reiter@osumc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ohio State University Comprehensive Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mira L Katz, PhD</last_name>
      <phone>614-293-6603</phone>
      <email>mira.katz@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Mira L Katz, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul L Reiter, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 7, 2016</lastchanged_date>
  <firstreceived_date>November 7, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University Comprehensive Cancer Center</investigator_affiliation>
    <investigator_full_name>Mira Katz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cancer prevention</keyword>
  <keyword>HPV</keyword>
  <keyword>Human papillomavirus vaccine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
